Eye implant aims to restore sight in advanced AMD patients
NCT ID NCT07164378
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 31 times
Summary
This study tests a small telescope-like implant called SING IMT™ for people with advanced age-related macular degeneration (AMD) who have poor central vision in both eyes. The device is placed inside the eye during surgery, either replacing or sitting in front of the existing lens. Researchers will check if it improves vision and is safe for 44 participants aged 55 and older.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION (AMD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Asklepios Augenklinik Nord-Heidberg
RECRUITINGHamburg, Germany
-
Augenklinik Sulzbach
RECRUITINGSulzbach, Germany
-
Augenklinik und Poliklinik des Universitätsklinikums
RECRUITINGWürzburg, Germany
-
Azienda Ospedaliero-Universitaria di Ferrara
RECRUITINGFerrara, Italy
-
CHU de Strasbourg
RECRUITINGStrasbourg, France
-
Centre d'Ophtalmologie Paradis-Monticelli
RECRUITINGMarseille, France
-
Hélios Ophtalmologie
RECRUITINGSaint-Jean-de-Luz, France
-
IRCCS Humanitas
RECRUITINGBergamo, Italy
-
MVZ Augenklinik Petrisberg GmbH
RECRUITINGTrier, Germany
-
Ospedale Generale Regionale "F. Miulli"
RECRUITINGBari, Italy
-
Policlinico Universitario Fondazione Agostino Gemelli
RECRUITINGRoma, Italy
-
Presidio Ospedaliero Palagi
RECRUITINGFlorence, Italy
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SING IMT™ implantable miniature telescope
What this could lead to
If successful, this device could help people with advanced AMD see better up close and far away, improving daily activities like reading and recognizing faces.
What could go wrong
This is a small, early-stage study with only 44 people. The device requires eye surgery, which carries risks like infection or vision loss. It does not cure AMD or restore normal vision.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.